Our Science Plan
To Beyond Celiac, a cure means real treatment options so those with celiac disease can live healthy lives and eat without fear.
To Beyond Celiac, a cure means real treatment options so those with celiac disease can live healthy lives and eat without fear.
With your support, Beyond Celiac will be the catalyst for the next wave of practical celiac disease research efforts.
The large, diverse celiac disease community continues to suffer from high daily burdens in coping with the disease, and we need treatments and a cure. Beyond Celiac has crafted its science plan to change the future for the 3.2 million Americans living with this serious autoimmune disorder.
Through Go Beyond Celiac and other initiatives, we are collecting and analyzing comprehensive data on the burden of celiac disease and gluten sensitivity. With this information, we can increase awareness and make a compelling case for larger investments from government agencies, pharmaceutical companies, biotech and more.
Patient Registry & Database
We have built, and continue to expand, a patient database and registry called Go Beyond Celiac. The website and app collect self-reported data to learn more about life with celiac disease.
NMQF Partnership
We have formed a partnership with the National Minority Quality Forum to unearth and address health disparities across multiple populations in celiac disease diagnosis and treatment.
We are funding promising research that quickly translates from scientific investigation to clinical use, speeding the development of treatments for patients.
Beyond Celiac partners with Sheffield to research neuropathology of celiac disease
Beyond Celiac partners with Janssen in a 2-year joint research grant program
RNA sequencing plays role in new research funded by Beyond Celiac
Meet the SSCD-Beyond Celiac research grant winner
Brain fog study presented at international celiac disease symposium
As the nation’s top recruiter for celiac disease clinical trials, we will continue educating our community about the importance of participating in trials. We will also work with pharmaceutical companies to ensure trials are designed with patient perspectives in mind.
We will invest significant resources to identify treatments that have been investigated or approved for other purposes but might also benefit celiac disease patients, reducing risk, cost and time to market for potential celiac disease treatments.
Watch a video interview with our CEO, Alice Bast, our Chief Scientist and Strategy Officer, Salvo Alesci, MD, and news reporter Diana Rocco.
Listen to our Celiac Straight Talk Podcast episode on our science plan: Apple Podcasts · PlayerFM · Stitcher
Beyond Celiac partners with pharmaceutical, health and biotech companies and organizations to advance our shared goals of unlocking celiac disease and accelerating a cure.
We embrace and leverage strategic partnerships and strong collaborations to advance our plan priorities, overcome challenges and maximize progress toward a cure.
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to
